HEMLIBRA sous-cutané sol inj 12 mg/0.4 ml flac
7680666940051
CH-66694
B02BX06
06.01.1.
Reimbursement limitations:
BLUTPRODUKTE
Calcul des prix des préparations sanguines sur la base du prix « ex factory », …
1 / 3
google
Details
- Product number
- 6669405
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- emicizumabum 12 mg, histidinum, acidum asparticum, argininum, poloxamerum 188, aqua ad iniectabile ad solutionem pro 0.4 ml.
Articles (1)
Hemlibra 12mg/0.4ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
12.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 709.20
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2025
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 66694
- Drug name
- Hemlibra, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- B02BX06
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 06/11/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 06.01.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- HEMLIBRA sous-cutané sol inj 12 mg/0.4 ml flac
- Description (DE)
- HEMLIBRA subkutan Inj Lös 12 mg/0.4 ml Durchstf
- Market launch
- 04/11/2024
- Narcotic (BTM)
- No